These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9988018)

  • 1. Beat-to-beat repolarization variability in amplitude and duration in LQTS patients with the SCN5A sodium channel gene mutation.
    Couderc JP; Zareba W; Burattini L; Konecki JA; Moss AJ
    J Electrocardiol; 1998; 31 Suppl():134. PubMed ID: 9988018
    [No Abstract]   [Full Text] [Related]  

  • 2. Beat-to-Beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation.
    Couderc JP; Zareba W; Burattini L; Moss AJ
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1581-92. PubMed ID: 10598960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
    Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation.
    Zareba W; Sattari MN; Rosero S; Couderc JP; Moss AJ
    Am J Cardiol; 2001 Dec; 88(11):1311-4. PubMed ID: 11728364
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
    Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
    Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel.
    Wang Q; Chen S; Chen Q; Wan X; Shen J; Hoeltge GA; Timur AA; Keating MT; Kirsch GE
    J Med Genet; 2004 May; 41(5):e66. PubMed ID: 15121794
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?
    Benhorin J; Taub R; Goldmit M; Kerem B; Kass RS; Windman I; Medina A
    Circulation; 2000 Apr; 101(14):1698-706. PubMed ID: 10758053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
    Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
    Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations.
    Wattanasirichaigoon D; Vesely MR; Duggal P; Levine JC; Blume ED; Wolff GS; Edwards SB; Beggs AH
    Am J Med Genet; 1999 Oct; 86(5):470-6. PubMed ID: 10508990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome.
    Van Langen IM; Birnie E; Alders M; Jongbloed RJ; Le Marec H; Wilde AA
    J Med Genet; 2003 Feb; 40(2):141-5. PubMed ID: 12566525
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
    Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
    J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A.
    Piippo K; Holmström S; Swan H; Viitasalo M; Raatikka M; Toivonen L; Kontula K
    Am J Cardiol; 2001 Apr; 87(7):909-11. PubMed ID: 11274952
    [No Abstract]   [Full Text] [Related]  

  • 19. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block.
    Lupoglazoff JM; Cheav T; Baroudi G; Berthet M; Denjoy I; Cauchemez B; Extramiana F; Chahine M; Guicheney P
    Circ Res; 2001 Jul; 89(2):E16-21. PubMed ID: 11463728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.